BCAX Smart Money
Bicara Therapeutics Inc. Common Stock
1W: -4.7%
1M: -7.0%
3M: -32.5%
YTD: +6.7%
1Y: +2.0%
$17.48
+0.59 (+3.49%)
Weekly Expected Move ±6.3%
$15
$16
$17
$18
$19
Credit Risk of going bust: lower than 88% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Bicara Therapeutics Inc. Common Stock would be worth roughly what it owes.
Total debt $1.2M against a stock market value of $1.16B.
Distance to default 12.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 54.2%; Altman Z'' 11.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Bicara Therapeutics Inc. Common Stock would be worth roughly what it owes.
Total debt $1.2M against a stock market value of $1.16B.
Distance to default 12.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.2M (short-term plus half of long-term), stock volatility 54.2%; Altman Z'' 11.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026189
Institutions Holding
+22 vs prior
164.0%
Ownership
+57.01%
42
New
67
Increased
51
Reduced
12
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Cohlhepp Ryan | officer: president, coo & interim ceo | S-Sale | 3,442 | $23.43 | $81K | Filing |
| 2026-09-08 | Cohlhepp Ryan | officer: president, coo & interim ceo | S-Sale | 14,058 | $22.77 | $320K | Filing |
| 2026-08-10 | Hyep Ivan | officer: chief financial officer | S-Sale | 12,500 | $27.97 | $350K | Filing |
| 2026-08-10 | Cohlhepp Ryan | officer: president and coo | S-Sale | 18,750 | $27.98 | $525K | Filing |
| 2026-08-10 | Mazumdar Claire | officer: chief executive officer | S-Sale | 10,000 | $27.98 | $280K | Filing |
| 2026-07-10 | Mazumdar Claire | officer: chief executive officer | S-Sale | 9,972 | $28.42 | $283K | Filing |
| 2026-07-10 | Mazumdar Claire | officer: chief executive officer | S-Sale | 28 | $29.68 | $831 | Filing |
| 2026-07-09 | Cohlhepp Ryan | officer: president and coo | S-Sale | 536 | $29.00 | $16K | Filing |
| 2026-07-08 | Cohlhepp Ryan | officer: president and coo | S-Sale | 22,833 | $28.76 | $657K | Filing |
| 2026-07-08 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,306 | $29.80 | $128K | Filing |
| 2026-07-08 | Cohlhepp Ryan | officer: president and coo | S-Sale | 1,075 | $30.35 | $33K | Filing |
| 2026-07-08 | Hyep Ivan | officer: chief financial officer | M-Option Exercise | 12,500 | $3.79 | $47K | Filing |
| 2026-07-08 | Hyep Ivan | officer: chief financial officer | S-Sale | 22,757 | $28.60 | $651K | Filing |
| 2026-07-08 | Hyep Ivan | officer: chief financial officer | S-Sale | 4,413 | $29.82 | $132K | Filing |
| 2026-07-08 | Hyep Ivan | officer: chief financial officer | S-Sale | 830 | $30.31 | $25K | Filing |
| 2026-05-21 | Hyep Ivan | officer: chief financial officer | S-Sale | 9,200 | $20.42 | $188K | Filing |
| 2026-05-18 | Mazumdar Claire | officer: chief executive officer | S-Sale | 2,978 | $20.35 | $61K | Filing |
| 2026-05-18 | Mazumdar Claire | officer: chief executive officer | S-Sale | 12,022 | $19.96 | $240K | Filing |
| 2026-05-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 8,000 | $20.29 | $162K | Filing |
| 2026-05-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,500 | $20.29 | $91K | Filing |
| 2026-04-27 | Raben David | officer: chief medical officer | S-Sale | 5,500 | $22.88 | $126K | Filing |
| 2026-04-21 | Hyep Ivan | officer: chief financial officer | S-Sale | 9,200 | $23.00 | $212K | Filing |
| 2026-04-20 | Mazumdar Claire | officer: chief executive officer | S-Sale | 15,000 | $23.61 | $354K | Filing |
| 2026-04-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,500 | $23.01 | $104K | Filing |
| 2026-04-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 8,000 | $23.01 | $184K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7,255,993 | $215M | — | 2026-06-30 | Filing |
| Siren, L.L.C. | 5,602,970 | $166M | -200,000 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 5,250,000 | $156M | -175,000 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 4,100,000 | $122M | +37,500 | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,848,090 | $114M | +1,004,383 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 3,171,015 | $94M | +3,171,015 | 2026-06-30 | Filing |
| RED TREE MANAGEMENT, LLC | 3,163,517 | $94M | -6,992 | 2026-06-30 | Filing |
| TPG GP A, LLC | 3,010,425 | $89M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,216,639 | $66M | +442,419 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,048,920 | $61M | +629,532 | 2026-06-30 | Filing |
| Royalty Pharma Sub-Manager, LLC | 2,388,150 | $61M | — | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 1,951,892 | $58M | +330,249 | 2026-06-30 | Filing |
| FMR LLC | 1,893,070 | $56M | -207,859 | 2026-06-30 | Filing |
| Omega Fund Management, LLC | 1,822,150 | $54M | -570,000 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,162,635 | $35M | +331,729 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,015,965 | $30M | +838,557 | 2026-06-30 | Filing |
| Jones Hill Capital LP | 892,621 | $27M | -367,515 | 2026-06-30 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 643,381 | $19M | -1 | 2026-06-30 | Filing |
| Aisling Capital Management LP | 568,919 | $17M | — | 2026-06-30 | Filing |
| Palo Alto Investors LP | 550,408 | $16M | — | 2026-06-30 | Filing |